Nothing Special   »   [go: up one dir, main page]

AU6098994A - Methods and agents for the diagnosis and treatment of rheumatoid arthritis - Google Patents

Methods and agents for the diagnosis and treatment of rheumatoid arthritis

Info

Publication number
AU6098994A
AU6098994A AU60989/94A AU6098994A AU6098994A AU 6098994 A AU6098994 A AU 6098994A AU 60989/94 A AU60989/94 A AU 60989/94A AU 6098994 A AU6098994 A AU 6098994A AU 6098994 A AU6098994 A AU 6098994A
Authority
AU
Australia
Prior art keywords
diagnosis
agents
treatment
methods
rheumatoid arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60989/94A
Inventor
Bruce A Clinton
Mario Gonzalez-Gronow
Salvatore V Pizzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trinity Laboratories Inc
Duke University
Original Assignee
Trinity Laboratories Inc
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trinity Laboratories Inc, Duke University filed Critical Trinity Laboratories Inc
Publication of AU6098994A publication Critical patent/AU6098994A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153Streptokinase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
AU60989/94A 1993-01-27 1994-01-27 Methods and agents for the diagnosis and treatment of rheumatoid arthritis Abandoned AU6098994A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US947193A 1993-01-27 1993-01-27
US009471 1993-01-27
PCT/US1994/001077 WO1994017411A1 (en) 1993-01-27 1994-01-27 Methods and agents for the diagnosis and treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
AU6098994A true AU6098994A (en) 1994-08-15

Family

ID=21737862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60989/94A Abandoned AU6098994A (en) 1993-01-27 1994-01-27 Methods and agents for the diagnosis and treatment of rheumatoid arthritis

Country Status (2)

Country Link
AU (1) AU6098994A (en)
WO (1) WO1994017411A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401689D0 (en) * 1994-01-28 1994-03-23 Univ Manchester Diagnosis and treatment of endocarditis
FR2773078B1 (en) * 1997-12-30 2000-05-26 Univ Toulouse USE OF CITRULLIN PEPTIDES DERIVED FROM FILAGGRIN FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS
KR101836968B1 (en) 2007-10-30 2018-03-12 필로겐 에스.피.에이. An antigen associated with rheumatoid arthritis
AR071169A1 (en) * 2008-03-31 2010-06-02 Council Scient Ind Res VARIANTS OF STREPTOQUINASE CONTAINING CISTEINE AND ITS COVALENTLY MODIFIED FORMS
EP2236517A1 (en) * 2009-03-31 2010-10-06 Takara Bio, Inc. Anti-fibronectin fragment monoclonal antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
DE3513915A1 (en) * 1985-04-17 1986-10-23 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin IMMUNOLOGICAL TEST KIT
US4980279A (en) * 1986-04-15 1990-12-25 Scripps Clinic And Research Foundation Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods

Also Published As

Publication number Publication date
WO1994017411A1 (en) 1994-08-04

Similar Documents

Publication Publication Date Title
AU7545594A (en) Implantable device for the treatment of aedemas
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
AU2103295A (en) Methods for the treatment of thrombosis
AU663833B2 (en) Surgical and/or clinical apparatus
AU6965996A (en) Method and apparatus for maintaining the position of body parts
AU4995693A (en) Apparatus and method for the treatment of blood
AU6379494A (en) Device for the application of electrical pulses in the treatment of biological issues
AU6041394A (en) Ultrasonic monitor
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
AU6801694A (en) The treatment of small animals
KR0166397B1 (en) Transistor & method of forming the same
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU7992994A (en) Immunoassay for the dectection of human autoantibodies
AU7376494A (en) Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
AU661364B2 (en) Method for administration of azauridine for the treatment of rheumatoid arthritis
ZA944772B (en) Treatment of fluids
AU4468093A (en) Composition and methods for the generation of bone
AU8131694A (en) Treatment for rheumatoid arthritis
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU6098994A (en) Methods and agents for the diagnosis and treatment of rheumatoid arthritis
EP0642337A1 (en) Dapsone and promin for the treatment of dementia.
EP0647708A3 (en) Process and apparatus for the propagation of yeast.
AU4441093A (en) Ultrasonic apparatus for health and beauty
AU7509294A (en) Method and system for the biological treatment of waste